a GREAT summary post from a Lie-HUB long...worth bringing it here for Ihang investors who may not be aware of HHSE's history...
Yes. Agreed!! I've NEVER sought BLOCKBUSTERS from HHSE at this stage in their growth, progress & development. Not from a stock trading at ONE SINGLE PENNY. Which is why I could NEVER understand the previous film title ribbing, comparisons to A-list films, with HUGE multi-million dollar production budgets, & the like: It's unreasonable.
The smaller theatrical, get PAID for the P&A, business-model, in which they get the title enough exposure to gain access into Walmart, Netflix, Redbox, Target, Costco, Sam's, Hastings, & the like; has served the company well.
They are singles. Not doubles, triples or home-runs. Singles that have ALLOWED the company to overcome a near-deadly, too-early attempt at a risky title in Joel Schumacher's film, "Twelve".
These base hits however have allowed HHSE to claw back into contention. Pay down debt, make new SIGNIFICANT hires, add higher-level films, attend CANNES Film Festival with their OWN BOOTH, gain international distribution-rights, & deliver more theatrical releases than ever before (with seemingly improving quality), etc..
This is what I was HOPING FOR all along with HHSE. Building VALUE for shareholders; LONG-TERM,....before taking a shot with higher-level & inherently riskier titles.
Now with Nasdaq-partner Cinedigm, HHSE is ready to launch VODwiz & make other VERY LOW COST, LOW-RISK revenue streams a REALITY. That's what I want.
6-18months from now I don't expect HHSE will be trading on the OTC. Nor do I expect them to be trading in this range. HHSE has silver potential (nickel, dime, etc.), & I hope to be here to WATCH THEM fulfill it!!
Nice & easy.
HHSE
Yes. Agreed!! I've NEVER sought BLOCKBUSTERS from HHSE at this stage in their growth, progress & development. Not from a stock trading at ONE SINGLE PENNY. Which is why I could NEVER understand the previous film title ribbing, comparisons to A-list films, with HUGE multi-million dollar production budgets, & the like: It's unreasonable.
The smaller theatrical, get PAID for the P&A, business-model, in which they get the title enough exposure to gain access into Walmart, Netflix, Redbox, Target, Costco, Sam's, Hastings, & the like; has served the company well.
They are singles. Not doubles, triples or home-runs. Singles that have ALLOWED the company to overcome a near-deadly, too-early attempt at a risky title in Joel Schumacher's film, "Twelve".
These base hits however have allowed HHSE to claw back into contention. Pay down debt, make new SIGNIFICANT hires, add higher-level films, attend CANNES Film Festival with their OWN BOOTH, gain international distribution-rights, & deliver more theatrical releases than ever before (with seemingly improving quality), etc..
This is what I was HOPING FOR all along with HHSE. Building VALUE for shareholders; LONG-TERM,....before taking a shot with higher-level & inherently riskier titles.
Now with Nasdaq-partner Cinedigm, HHSE is ready to launch VODwiz & make other VERY LOW COST, LOW-RISK revenue streams a REALITY. That's what I want.
6-18months from now I don't expect HHSE will be trading on the OTC. Nor do I expect them to be trading in this range. HHSE has silver potential (nickel, dime, etc.), & I hope to be here to WATCH THEM fulfill it!!
Nice & easy.
HHSE
